Clinical Trial Update: Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluated cabazitaxel with or without carboplatin in patients with previously treated metastatic castration-resistant prostate cancer; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-30